Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Lennard

Showing results (41-50 of 88) with videos related to

Pageof 9
Sort By:
The British Journal of Dermatology|December 1, 1985
Skin cancer in renal transplant recipients is associated with increased concentrations of 6-thioguanine nucleotide in red blood cellsL Lennard, S Thomas, C I Harrington, et al.
British Journal of Clinical Pharmacology|November 1, 1984
Azathioprine metabolism in kidney transplant recipientsL Lennard, C B Brown, M Fox, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
Disturbance of 6-mercaptopurine metabolism by cotrimoxazole in childhood lymphoblastic leukaemiaC A Rees, L Lennard, J S Lilleyman, et al.
British Journal of Clinical Pharmacology|October 1, 1983
Childhood leukaemia: a relationship between intracellular 6-mercaptopurine metabolites and neutropeniaL Lennard, C A Rees, J S Lilleyman, et al.
Leukemia|September 1, 1992
Interleukin-2 induction of lymphokine-activated killer activity in the peripheral blood of an acute lymphoblastic leukaemia patient--case studyA M Dickinson, A L Lennard, R Cartner, et al.
Lancet (London, England)|July 28, 1990
Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemiaL Lennard, J S Lilleyman, J Van Loon, et al.
Blood Reviews|September 1, 1994
Autologous bone marrow transplantation in acute lymphoblastic leukaemiaG H Jackson, P R Taylor, A L Lennard, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
An effective oral combination in advanced relapsed Hodgkin's disease prednisolone, etoposide, chlorambucil and CCNUA L Lennard, P J Carey, G H Jackson, et al.
Clinical Pharmacology and Therapeutics|January 1, 1987
Thiopurine pharmacogenetics in leukemia: correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrationsL Lennard, J A Van Loon, J S Lilleyman, et al.
Molecular Immunology|November 28, 2016
The Fli-1 transcription factor is a critical regulator for controlling the expression of chemokine C-X-C motif ligand 2 (CXCL2)Ning Lou, Mara L Lennard Richard, Jin Yu, et al.
Pageof 9

Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
The British Journal of Dermatology|December 1, 1985
Skin cancer in renal transplant recipients is associated with increased concentrations of 6-thioguanine nucleotide in red blood cellsL Lennard, S Thomas, C I Harrington, et al.
British Journal of Clinical Pharmacology|November 1, 1984
Azathioprine metabolism in kidney transplant recipientsL Lennard, C B Brown, M Fox, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
Disturbance of 6-mercaptopurine metabolism by cotrimoxazole in childhood lymphoblastic leukaemiaC A Rees, L Lennard, J S Lilleyman, et al.
British Journal of Clinical Pharmacology|October 1, 1983
Childhood leukaemia: a relationship between intracellular 6-mercaptopurine metabolites and neutropeniaL Lennard, C A Rees, J S Lilleyman, et al.
Leukemia|September 1, 1992
Interleukin-2 induction of lymphokine-activated killer activity in the peripheral blood of an acute lymphoblastic leukaemia patient--case studyA M Dickinson, A L Lennard, R Cartner, et al.
Lancet (London, England)|July 28, 1990
Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemiaL Lennard, J S Lilleyman, J Van Loon, et al.
Blood Reviews|September 1, 1994
Autologous bone marrow transplantation in acute lymphoblastic leukaemiaG H Jackson, P R Taylor, A L Lennard, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
An effective oral combination in advanced relapsed Hodgkin's disease prednisolone, etoposide, chlorambucil and CCNUA L Lennard, P J Carey, G H Jackson, et al.
Clinical Pharmacology and Therapeutics|January 1, 1987
Thiopurine pharmacogenetics in leukemia: correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrationsL Lennard, J A Van Loon, J S Lilleyman, et al.
Molecular Immunology|November 28, 2016
The Fli-1 transcription factor is a critical regulator for controlling the expression of chemokine C-X-C motif ligand 2 (CXCL2)Ning Lou, Mara L Lennard Richard, Jin Yu, et al.
Pageof 9